These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 34974568)

  • 1. Clinical Outcome of paediatric ewing sarcoma and significance of pathological necrosis for mortality after neoadjuvant chemotherapy: Single institutional study.
    Sindhu II; Mehreen A; Wali RM; Abubakar M
    J Pak Med Assoc; 2021 Oct; 71(10):2344-2349. PubMed ID: 34974568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The histological response to chemotherapy as a predictor of the oncological outcome of operative treatment of Ewing sarcoma.
    Wunder JS; Paulian G; Huvos AG; Heller G; Meyers PA; Healey JH
    J Bone Joint Surg Am; 1998 Jul; 80(7):1020-33. PubMed ID: 9698007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of FDG PET/CT in patients treated with neoadjuvant chemotherapy for localized bone sarcomas.
    Palmerini E; Colangeli M; Nanni C; Fanti S; Marchesi E; Paioli A; Picci P; Cambioli S; Donati D; Cevolani L; De Paolis M; Gambarotti M; Ferrari S
    Eur J Nucl Med Mol Imaging; 2017 Feb; 44(2):215-223. PubMed ID: 27645694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical impact of post-induction resolution of pulmonary lesions in metastatic Ewing sarcoma.
    Halalsheh H; Kaste SC; Krasin MJ; Sykes A; Sahr N; Spunt SL; Federico SM; Bishop MW
    Pediatr Blood Cancer; 2020 Apr; 67(4):e28150. PubMed ID: 31944574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complete tumor necrosis after neoadjuvant chemotherapy defines good responders in patients with Ewing sarcoma.
    Lozano-Calderón SA; Albergo JI; Groot OQ; Merchan NA; El Abiad JM; Salinas V; Gomez Mier LC; Montoya CS; Ferrone ML; Ready JE; Linares FJ; Levin AS; Peleteiro Pensado M; Pozo Kreilinger JJ; Ruiz IB; Ortiz-Cruz EJ; Gebhardt MC; Cote GM; Choy E; Spentzos D; Hung YP; Deshpande V; Chebib IA; McCulloch RA; Farfalli G; Aponte Tinao L; Morris CD; Petur Nielsen G; Anderson ME; Jeys LM
    Cancer; 2023 Jan; 129(1):60-70. PubMed ID: 36305090
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ewing sarcoma of the hand or foot.
    Froeb D; Ranft A; Boelling T; Paulussen M; Klco-Brosius S; Jürgens H; Dirksen U
    Klin Padiatr; 2012 Oct; 224(6):348-52. PubMed ID: 23143762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypoalbuminaemia is an independent predictor of poor outcome in metastatic Ewing's sarcoma family of tumours: a single institutional experience of 150 cases treated with uniform chemotherapy protocol.
    Biswas B; Rastogi S; Khan SA; Shukla NK; Deo SV; Agarwala S; Sharma DN; Thulkar S; Vishnubhatla S; Pathania S; Bakhshi S
    Clin Oncol (R Coll Radiol); 2014 Nov; 26(11):722-9. PubMed ID: 24919857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. What is the impact of local control in Ewing sarcoma: analysis of the first Brazilian collaborative study group - EWING1.
    Becker RG; Gregianin LJ; Galia CR; Jesus-Garcia Filho R; Toller EA; Badell G; Nakagawa SA; David A; Baptista AM; Yonamime ES; Serafini OA; Penna V; Santos JFC; Brunetto AL;
    BMC Cancer; 2017 Jun; 17(1):420. PubMed ID: 28619077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ewing's sarcoma: only patients with 100% of necrosis after chemotherapy should be classified as having a good response.
    Albergo JI; Gaston CL; Laitinen M; Darbyshire A; Jeys LM; Sumathi V; Parry M; Peake D; Carter SR; Tillman R; Abudu AT; Grimer RJ
    Bone Joint J; 2016 Aug; 98-B(8):1138-44. PubMed ID: 27482030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes with nondose-dense chemotherapy for Ewing sarcoma: A practical approach for the developing world.
    Parambil BC; Vora T; Sankaran H; Prasad M; Bakshi A; Puri A; Gulia A; Qureshi S; Laskar S; Khanna N; Shah S; Ramadwar M; Kembhavi S; Chinnaswamy G; Banavali S
    Pediatr Blood Cancer; 2020 Nov; 67(11):e28604. PubMed ID: 32706522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extraskeletal Ewing sarcomas in late adolescence and adults: a study of 37 patients.
    Tao HT; Hu Y; Wang JL; Cheng Y; Zhang X; Wang H; Zhang SJ
    Asian Pac J Cancer Prev; 2013; 14(5):2967-71. PubMed ID: 23803063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary cutaneous and subcutaneous Ewing sarcoma.
    Di Giannatale A; Frezza AM; Le Deley MC; Marec-Bérard P; Benson C; Blay JY; Bui B; Judson I; Oberlin O; Whelan J; Gaspar N
    Pediatr Blood Cancer; 2015 Sep; 62(9):1555-61. PubMed ID: 25894676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can postoperative radiotherapy be omitted in localised standard-risk Ewing sarcoma? An observational study of the Euro-E.W.I.N.G group.
    Foulon S; Brennan B; Gaspar N; Dirksen U; Jeys L; Cassoni A; Claude L; Seddon B; Marec-Berard P; Whelan J; Paulussen M; Streitbuerger A; Oberlin O; Juergens H; Grimer R; Le Deley MC
    Eur J Cancer; 2016 Jul; 61():128-36. PubMed ID: 27176931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extraosseous Ewing sarcoma in children and adolescents: A retrospective series from a referral pediatric oncology center.
    Livellara V; Bergamaschi L; Puma N; Chiaravalli S; Podda M; Casanova M; Gasparini P; Pecori E; Alessandro O; Nigro O; Sironi G; Gattuso G; Terenziani M; Spreafico F; Meazza C; Biassoni V; Schiavello E; Massimino M; Luksch R; Ferrari A
    Pediatr Blood Cancer; 2022 May; 69(5):e29512. PubMed ID: 34962687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Individual risk evaluation for local recurrence and distant metastasis in Ewing sarcoma: A multistate model: A multistate model for Ewing sarcoma.
    Bosma SE; Rueten-Budde AJ; Lancia C; Ranft A; Dirksen U; Krol AD; Gelderblom H; van de Sande MAJ; Dijkstra PDS; Fiocco M
    Pediatr Blood Cancer; 2019 Nov; 66(11):e27943. PubMed ID: 31389188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonmetastatic pelvic Ewing sarcoma: report of the French society of pediatric oncology.
    Carrie C; Mascard E; Gomez F; Habrand JL; Alapetite C; Oberlin O; Moncho V; Hoffstetter S
    Med Pediatr Oncol; 1999 Nov; 33(5):444-9. PubMed ID: 10531567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High Response Rates and Promising Outcomes of Patients with Relapsed Ewing Sarcoma, Especially in Adolescents and Young Adults Treated on a Novel Hybrid Salvage Chemotherapy Regimen.
    Vijayasekharan K; Ramanathan S; Chinnaswamy G; Prasad M; Gulia A; Janu A; Rekhi B; Ramadwar M; Khanna N; Laskar S; Puranadare N; Bajpai J; Puri A; Banavali S; Vora T
    J Adolesc Young Adult Oncol; 2021 Apr; 10(2):185-192. PubMed ID: 32706630
    [No Abstract]   [Full Text] [Related]  

  • 18. Adult Ewing sarcoma: survival and local control outcomes in 36 patients with metastatic disease.
    Ahmed SK; Robinson SI; Okuno SH; Rose PS; Issa Laack NN
    Am J Clin Oncol; 2014 Oct; 37(5):423-9. PubMed ID: 23388557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment and outcome of patients with thoracic tumors of the Ewing sarcoma family: A report from the Cooperative Weichteilsarkom Studiengruppe CWS-81, -86, -91, -96, and -2002P trials.
    Seitz G; Urla C; Sparber-Sauer M; Schuck A; Vokuhl C; Blank B; Klingebiel T; Kazanowska B; Fuchs J; Koscielniak E
    Pediatr Blood Cancer; 2019 Mar; 66(3):e27537. PubMed ID: 30421578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes and prognostic factors for Ewing-family tumors of the extremities.
    Biswas B; Rastogi S; Khan SA; Mohanti BK; Sharma DN; Sharma MC; Mridha AR; Bakhshi S
    J Bone Joint Surg Am; 2014 May; 96(10):841-9. PubMed ID: 24875025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.